drugset / Trial / NCT01406548
Safety and Efficacy of Multiple Dosing Regimens of BPS804 in Post Menopausal Women With Low Bone Mineral Density
Phase 2
Completed
44 enrolled
Ultragenyx Pharmaceutical Inc
Mereo BioPharma · collabNovartis · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is designed to provide information on the safety, tolerability, pharmacokinetics (PK) and bone biomarker response following multiple BPS804 administration in multiple dosing regimens. This information will permit a comparison of the possible risks and benefits of different dosing regimens of the study drug to enable optimal doses and dose intervals to be tested in subsequent studies.
Timeline
- Start
- 2011-07
- Primary completion
- 2013-10
- Completion
- 2013-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Setrusumab | Monoclonal antibody | 20 mg/kg | — |